Clinical trial
SeroCOVIDial Study: Assessment of SARS-COV2 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study
NCT04420338 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SeroCOVIDial Study: Assessment of SARS-COV2 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 5, 2020
- Completion date
- December 15, 2020
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
caregivers of chronic hemodialysis patients, chronic hemodialysis patients